Substrate Report for: DMCPE

A novel carboxylesterase designated as RoCE was identified from Rhodococcus opacus with high activity and enantioselectivity toward asymmetric esters such as ethyl 2,2-dimethylcyclopropane-1-carboxylate (DMCPE). Moreover, RoCE could catalyze the enantioselective resolution of near-symmetric oxyheterocyclic esters such as ethyl tetrahydro-2H-pyran-2-carboxylate (THPCE), which are generally regarded as 'hard-to-be-discriminated' by chemical and biological catalysts. The crystal structure of RoCE was resolved at a resolution of 1.78 A. Theozyme calculation, MD simulations and pre-reaction state analysis were performed to clarify the molecular basis for the enantioselectivity toward oxyheterocyclic carboxylic acid esters with a nearly symmetric structure. F166 plays an important role in manipulating the enantioselective recognition of (S)- and (R)-DMCPE through steric effect. The intrinsic symmetric structure of (S)- and (R)-THPCE is mainly responsible for the relatively lower enantioselectivity than DMCPE. By introducing hydrogen bond interactions, a mutant M144T was successfully obtained with an E value of 2.44-fold that of WT. MD simulations further prove the increased enantioselectivity of M144T in terms of pre-reaction state and binding free energy. This study provides a novel carboxylesterase and important molecular insights into the enantioselectivity of carboxylesterase toward heterocyclic carboxylic acid esters with a nearly symmetric structure, which will facilitate further engineering of the enantioselectivity of carboxylesterase.

(S)-(+)-2,2-Dimethylcyclopropane carboxylic acid [(S)-(+)-DMCPA] is a key chiral intermediate for production of Cilastatin, an excellent renal dehydropeptidase-I inhibitor. In this study, a new method for preparation of (S)-(+)-DMCPA with microbial esterases was investigated. A microbial screening program obtained six esterase-producing isolates that could display relatively high activities and enantioselectivities using racemic ethyl 2,2-dimethylcyclopropane carboxylate (DMCPE) as screening substrate, aiming at forming optically pure (S)-(+)-DMCPA. Further selection was carried out with substrates having different alcohol moieties, including methyl, ethyl, and 2-chloroethyl esters. Finally, one of these strains, numbered ECU1013, with high enantioselectivity toward the hydrolytic resolution of methyl 2,2-dimethylcyclopropane carboxylate (DMCPM), afforded the (S)-product in 92 % ee, and was later identified as Rhodococcus sp. According to our research, there were several active esterases to DMCPM in cells of Rhodococcus sp. ECU1013; however, (S)-preferential esterase was selectively enriched based on the time-dependent profile of esterases biosynthesis, thereby the enantiomeric excess of biotransformation product (ee p) was constantly increased, finally maintained at 95 % (S). To improve the yield, various organic solvents were employed for better dispersion of the hydrophobic substrate. As a result, (+/-)-DMCPM of up to 400 mM in the organic phase of isooctane was enantioselectively hydrolyzed into (S)-(+)-DMCPA, with an isolation yield of 38 % and a further increase of ee p to 99 %.